Analytical development and validation services supported by experienced analytical scientists and state-of-the-art equipment are integral to any drug development program. At Lonza, we provide thorough analytical support, candidate screening, drug product analysis and phase-appropriate method development and validation for drug substances, particle-engineered intermediates, and drug products. Our services are tailored to your specific program and range from development of early-stage compound handling protocols to optimization of Quality Control methods during late stage development.

Based on the experience of developing thousands of small molecules and a track record in cGMP compliance, we are well positioned to partner with you on all development and analytical aspects of your API.

We understand your analytical objectives throughout the drug development process and work with you to ensure that appropriate methodologies are available at all stages, e.g.

  • Early handling protocols for your compound
  • Analytical methods to support your early formulation prototype characterization including assay, purity and dissolution
  • Phase-appropriate methods to support batch release and stability testing of early phase compound, intermediate or drug product manufacturing
  • Method optimization to ensure robustness
  • Finalization of analytical methods to support your Phase III, registration and commercial drug substance or drug product manufacturing to cGMP guidelines
  • Further method optimization to support cGMP process intensification

We also provide full analytical testing from preclinical development through late stage clinical and commercial production of drug compounds, intermediates and finished drug products, e.g.

  • Preclinical prototype evaluations
  • Excipient compatibility studies
  • Finished product testing including purity, dissolution and physical characterization
  • Full range of ICH stability studies (storage and testing)

Our experienced teams of analysts and our extensive Good Laboratory Practice (GLP)-compliant facilities throughout the globe provide support for development of early formulations, clinical-trial materials, and commercial products. Once validated, analytical methods are routinely used for release of the products in our quality control laboratories.

For optimum responsiveness, we have located state-of-the-art analytical-development laboratories at each of our integrated product-development sites, providing rapid analytical services to fit your development timelines.

Related content

API Research & Development Services
We provide full development services for small molecules across a range of standard and advanced chemical synthesis routes.
SimpliFiH® Solutions: First-in-Human Services
We can provide integrated drug substance and drug product services for preclinical studies and phase I clinical trials.
Product Design and Preformulation Development
At Lonza, we apply extensive product design, preformulation, and technology expertise to successfully advance challenging compounds and improve overall speed to market. We offer premier depth in addressing bioavailability challenges and modulating pharmac...
Formulation and Product Development
We provide integrated preformulation, formulation and product development services to our biopharmaceutical customers using a broad range of enabling technologies to address formulation challenges.
Drug Product Process Development and Optimization
We provide process development, optimization and validation as part of our integrated services spanning feasibility studies, clinical trial material manufacture and commercial production of drug substances, intermediates and finished drug products.
Regulatory Affairs Services
Our Regulatory Affairs Services provides an extensive CMC writing and procedural offering to clients. We use our hands-on practical experience from early development through clinical programs (IND & IMPD), support for preparation and approval of licen...